Karen Jean Ferrante Insider Trading $COGT Cogent Biosciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Jean Ferrante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Jean Ferrante. Karen Jean Ferrante is in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in MACROGENICS INC ($MGNX) and Head Res. & Dev. & Chief Med. in Tokai Pharmaceuticals Inc ($TKAI) and Director in Unum Therapeutics Inc. ($UMRX) and Director in Baxalta Inc ($BXLT).
Karen Jean Ferrante in Cogent Biosciences, Inc.
Trading Symbol: COGTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen Jean Ferrante: Director
Holdings: 0 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen Jean Ferrante in Cogent Biosciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXLT, COGT, ELDN, MGNX, PGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | COGT | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 9.08 | 2,121 | 19,259 | 2,121 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Jan 06 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 7.62 | 1,575 | 12,000 | 1,575 | |
Oct 02 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.26 | 8,878 | 20,064 | 8,878 | |
Jul 06 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.47 | 38,487 | 18,089 | 38,487 | |
Jun 11 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
Apr 08 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.35 | 54,422 | 19,020 | 54,422 | |
Oct 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 1.41 | 13,646 | 19,241 | 13,646 | |
Jul 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.41 | 6,199 | 14,940 | 6,199 | |
Jun 20 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.70 | 14,331 | 38,694 | 14,331 | |
Apr 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.40 | 4,047 | 17,807 | 4,047 | |
Jan 04 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.47 | 4,073 | 18,206 | 4,073 | |
Oct 03 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 10.37 | 1,769 | 18,345 | 1,769 | |
Sep 26 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 14.57 | 1,261 | 18,373 | 1,261 |
Page: 1